
|Articles|July 9, 2015
Patient-centric innovation in packaging moves beyond regulatory requirements to deliver brand differentiation and increased sales
Author(s)WestRock
Not so long ago, pharmaceutical brand managers considered drug packaging an afterthought. Today, packaging not only matters, it is quickly becoming one of the most important considerations in the growth and success of any drug product. Manufacturers now consider innovative, smart packaging that pleases patients in their new roles as consumers, and encourages brand loyalty to be a game changer in an increasingly competitive and crowded biopharmaceutical market.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
2
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
3
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5




